查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1880855

全球黴漿菌檢測市場

Mycoplasma Testing
出版日期: | 出版商: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 英文 158 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

全球黴漿菌檢測市場預計2030年將達到19億美元

全球黴漿菌檢測市場預計在2024年達到11億美元，預計到2030年將達到19億美元，在分析期間（2024-2030年）內複合年成長率（CAGR）為8.6%。本報告分析的細分市場之一「檢測、試劑盒和試劑」預計將以9.4%的複合年成長率成長，並在分析期結束時達到9.408億美元。服務細分市場預計在分析期間將以8.1%的複合年成長率成長。

美國市場規模估計為2.919億美元，而中國市場預計將以12.7%的複合年成長率成長。

據估計，2024年美國黴漿菌檢測市場規模將達到2.919億美元。作為世界第二大經濟體，中國市場預計到2030年將達到4.832億美元，2024年至2030年的複合年成長率（CAGR）為12.7%。其他值得關注的區域市場分析包括日本和加拿大，預計在分析期間內，這兩個國家的複合年成長率分別為4.4%和7.7%。在歐洲，德國的複合年成長率預計約為5.4%。

全球黴漿菌檢測市場－主要市場趨勢與促進因素概述

什麼是黴漿菌檢測？為什麼它對生物製藥和細胞培養至關重要？

黴漿菌檢測是指檢測細胞培養物、生物製藥產品和疫苗中的黴漿菌污染。黴漿菌是一類無細胞壁的細菌，可污染生物製藥生產所使用的細胞培養。由於其體積微小且具有柔韌性，它們能夠穿過傳統過濾器，在生物技術生產過程中造成污染而不被發現，這可能會損害產品的安全性和有效性。黴漿菌污染會導致細胞生理改變、實驗結果不準確、產品回想。因此，定期檢測對於實驗室、製藥公司和生物製藥生產設施至關重要。黴漿菌檢測對於確保符合監管標準以及維護用於醫療和研究的細胞產品的完整性至關重要。

技術進步如何改變黴漿菌檢測方法？

技術創新顯著提高了黴漿菌檢測的準確性、速度和可靠性。傳統上，黴漿菌檢測採用培養法，耗時費力，需數週才能獲得結果。然而，聚合酵素鏈鎖反應(PCR) 和即時PCR (qPCR) 等分子診斷技術的進步徹底改變了黴漿菌檢測，實現了更快、更靈敏、更特異性的污染檢測。此外，核酸擴增技術 (NAAT) 和次世代定序(NGS) 技術進一步提升了偵測能力，能夠辨識更多種類的黴漿菌。自動化檢測平台也減少了常規檢測所需的時間和人力，使實驗室和生產設施更輕鬆地即時確保無污染環境。

監管要求和行業標準如何影響黴漿菌檢測的需求？

生物製藥生產中嚴格的監管要求以及對安全有效的生物技術產品日益成長的需求，推動了黴漿菌檢測的需求。美國食品藥物管理局(FDA) 和歐洲藥品管理局 (EMA) 等監管機構要求對細胞製品、生物製藥和疫苗進行常規黴漿菌檢測，以確保產品安全並防止污染。遵守這些法規對於製藥公司維持產品核准、避免代價高昂的延誤和召回至關重要。生物製藥產業的蓬勃發展以及委外研發機構(CRO) 和受託製造廠商(CMO) 的擴張，也推動了更快、更可靠的黴漿菌檢測方法的應用。此外，隨著細胞和基因療法的興起，嚴格的檢測通訊協定顯得特別重要，因為污染風險可能對產品療效產生重大影響。

黴漿菌檢測市場的主要成長要素是什麼？

黴漿菌檢測市場的成長受多種因素驅動，包括分子診斷技術的進步、監管力度的加強以及生物製藥生產的擴張。快速、高精度的檢測方法（例如PCR和NGS）的普及提高了污染檢測能力，使得這些技術在業界日益普及。生物製藥、疫苗和細胞療法的日益普及也推動了對可靠黴漿菌檢測的需求成長，因為這些產品特別容易受到污染。此外，監管要求強制對生物製藥和細胞培養物進行定期檢測，也促進了先進黴漿菌檢測解決方案的應用。製藥業對合約研究和生產服務的日益依賴是另一個促進因素。這些機構需要完善的檢測通訊協定來確保合規性和產品安全。最後，生物技術流程中對品管的日益重視，推動了更有效率、更自動化的檢測平台的持續發展，進一步促進了市場成長。

部分：

產品與服務（檢測、試劑盒/試劑、服務、設備）、技術（核酸檢測 (NAT)、酵素連結免疫吸附試驗 (ELISA)、染色、其他技術）、應用（細胞株檢測、臨終細胞檢測、病毒檢測、其他應用）

受訪公司範例

  • American Type Culture Collection（ATCC）
  • Biological Industries Israel Beit Haemek Ltd.
  • Biounique Testing Laboratories Inc.
  • Charles River Laboratories International, Inc.
  • Invivogen
  • Lonza Group AG
  • Merck KgaA
  • Norgen Biotek Corporation
  • Promocell GmbH
  • Roche Diagnostics（Schweiz）AG
  • SGS SA
  • Thermo Fisher Scientific, Inc.
  • Wuxi Apptec Co., Ltd.

人工智慧整合

我們正在利用檢驗的專家內容和人工智慧工具，革新市場和競爭情報分析。

Market Glass, Inc. 並沒有查詢LLM 或產業專用的SLM 的典型方法，而是建立了一個由世界各地領域專家精心策劃的內容庫，其中包括影片轉錄、BLOG、搜尋引擎研究以及大量的公司、產品/服務和市場數據。

關稅影響係數

在最新發布的報告中，Market Glass, Inc. 將關稅對地理市場的影響納入考量，並根據公司總部所在地、製造地以及進出口（成品和OEM產品）情況，預測企業競爭地位的變化。這種複雜多變的市場現實會從多個方面影響競爭對手，包括增加銷貨成本、降低盈利和重組供應鏈，同時也會影響微觀和宏觀市場動態。

目錄

第1章調查方法

第2章執行摘要

  • 市場概覽
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章 市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 西班牙
  • 俄羅斯
  • 其他歐洲
  • 亞太地區
  • 澳洲
  • 印度
  • 韓國
  • 亞太其他地區
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中東
  • 伊朗
  • 以色列
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 其他中東地區
  • 非洲

第4章 競賽

簡介目錄
Product Code: MCP13520

Global Mycoplasma Testing Market to Reach US$1.9 Billion by 2030

The global market for Mycoplasma Testing estimated at US$1.1 Billion in the year 2024, is expected to reach US$1.9 Billion by 2030, growing at a CAGR of 8.6% over the analysis period 2024-2030. Assays, Kits & Reagents, one of the segments analyzed in the report, is expected to record a 9.4% CAGR and reach US$940.8 Million by the end of the analysis period. Growth in the Services segment is estimated at 8.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$291.9 Million While China is Forecast to Grow at 12.7% CAGR

The Mycoplasma Testing market in the U.S. is estimated at US$291.9 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$483.2 Million by the year 2030 trailing a CAGR of 12.7% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.4% and 7.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.4% CAGR.

Global Mycoplasma Testing Market - Key Trends & Drivers Summarized

What Is Mycoplasma Testing and Why Is It Essential in Biopharmaceuticals and Cell Cultures?

Mycoplasma testing refers to the detection of mycoplasma contamination in cell cultures, biopharmaceutical products, and vaccines. Mycoplasmas are a group of bacteria that lack a cell wall and can cause contamination in cell cultures used in biopharmaceutical production. Due to their small size and flexibility, they can pass through conventional filters and contaminate biotechnological processes without detection, compromising product safety and efficacy. Mycoplasma contamination can lead to alterations in cell physiology, inaccurate experimental results, and product recalls, making routine testing essential in laboratories, pharmaceutical companies, and biopharmaceutical production facilities. Testing for mycoplasma is critical for ensuring compliance with regulatory standards and maintaining the integrity of cell-based products used in medical treatments and research.

How Are Technological Advances Shaping Mycoplasma Testing Methods?

Technological innovations are significantly improving the accuracy, speed, and reliability of mycoplasma testing. Traditionally, mycoplasma detection was performed using culture-based methods, which are time-consuming and labor-intensive, taking weeks to yield results. However, advancements in molecular diagnostics, such as polymerase chain reaction (PCR) and real-time PCR (qPCR), have revolutionized mycoplasma testing by enabling faster, more sensitive, and specific detection of contamination. Additionally, nucleic acid amplification techniques (NAATs) and next-generation sequencing (NGS) technologies are further enhancing detection capabilities, allowing for the identification of a broader range of mycoplasma species. Automated testing platforms are also reducing the time and labor required for routine testing, making it easier for laboratories and production facilities to ensure contamination-free environments in real-time.

How Are Regulatory Requirements and Industry Standards Impacting the Demand for Mycoplasma Testing?

Stringent regulatory requirements in biopharmaceutical production and the increasing demand for safe and effective biotechnological products are driving the demand for mycoplasma testing. Regulatory bodies such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) mandate routine mycoplasma testing for cell-based products, biologics, and vaccines to ensure product safety and prevent contamination. Compliance with these regulations is critical for pharmaceutical companies to maintain product approval and avoid costly delays or recalls. The growing biopharmaceutical industry, along with the expansion of contract research organizations (CROs) and contract manufacturing organizations (CMOs), is also pushing the adoption of faster and more reliable mycoplasma testing methods. Moreover, with the rise in cell and gene therapies, where contamination risks can significantly affect product viability, the need for stringent testing protocols has become even more essential.

What Are the Key Growth Drivers in the Mycoplasma Testing Market?

The growth in the mycoplasma testing market is driven by several factors, including advancements in molecular diagnostics, increased regulatory scrutiny, and the expansion of biopharmaceutical production. The shift toward faster and more precise testing methods, such as PCR and NGS, is enhancing contamination detection, making these technologies increasingly popular in the industry. The rising prevalence of biologics, vaccines, and cell-based therapies is also contributing to the growing demand for reliable mycoplasma testing, as these products are particularly susceptible to contamination. Additionally, regulatory requirements mandating regular testing of biologics and cell cultures are further pushing the adoption of advanced mycoplasma detection solutions. The growing use of contract research and manufacturing services in the pharmaceutical industry is another driver, as these organizations require robust testing protocols to ensure compliance and product safety. Lastly, the increasing focus on quality control in biotechnological processes is promoting the continuous development of more efficient and automated testing platforms, further accelerating market growth.

SCOPE OF STUDY:

The report analyzes the Mycoplasma Testing market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Offering (Assays, Kits & Reagents, Services, Instruments); Technique (Nucleic Acid Testing (NAT), ELISA, Staining, Other Techniques); Application (Cell Line Testing, End-of-Production Cell Testing, Virus Testing, Other Applications)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 11 Featured) -

  • American Type Culture Collection (ATCC)
  • Biological Industries Israel Beit Haemek Ltd.
  • Biounique Testing Laboratories Inc.
  • Charles River Laboratories International, Inc.
  • Invivogen
  • Lonza Group AG
  • Merck KgaA
  • Norgen Biotek Corporation
  • Promocell GmbH
  • Roche Diagnostics (Schweiz) AG
  • SGS SA
  • Thermo Fisher Scientific, Inc.
  • Wuxi Apptec Co., Ltd.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy
    • How Trump's Tariffs Impact the Market? The Big Question on Everyone's Mind
    • Global Economic Update
    • Mycoplasma Testing - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Adoption of Biopharmaceuticals Spurs Demand for Mycoplasma Testing in Manufacturing
    • Increasing Regulatory Scrutiny Expands Addressable Market for Mycoplasma Testing in Drug Development
    • Technological Advancements in PCR-Based Testing Strengthen Business Case for Rapid Mycoplasma Detection
    • Growth in Cell Culture-Based Research Drives Adoption of Routine Mycoplasma Testing in Laboratories
    • Increasing Use of Mycoplasma Testing in Gene and Cell Therapies Expands Market for Advanced Testing Solutions
    • Rising Focus on Contamination Control in Biomanufacturing Propels Growth in Mycoplasma Testing Services
    • Expansion of Contract Research Organizations (CROs) Fuels Demand for Outsourced Mycoplasma Testing
    • Increasing Investment in Vaccine Development Strengthens Market for Mycoplasma Testing in Biopharma R&D
    • Expansion of Stem Cell Research and Regenerative Medicine Spurs Demand for Mycoplasma Testing in Cell Cultures
    • Technological Innovations in Digital PCR Propel Growth in Sensitivity and Speed of Mycoplasma Detection
    • Rising Demand for Mycoplasma-Free Biological Products Drives Adoption of Testing Protocols in Drug Development
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Mycoplasma Testing Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Mycoplasma Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Mycoplasma Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Mycoplasma Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Assays, Kits & Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Assays, Kits & Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Assays, Kits & Reagents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Nucleic Acid Testing (NAT) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Nucleic Acid Testing (NAT) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Nucleic Acid Testing (NAT) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for ELISA by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for ELISA by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for ELISA by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Staining by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Staining by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Staining by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Other Techniques by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Other Techniques by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Other Techniques by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Cell Line Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Cell Line Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Cell Line Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for End-of-Production Cell Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for End-of-Production Cell Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for End-of-Production Cell Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Virus Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Virus Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: World 15-Year Perspective for Virus Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Mycoplasma Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 38: USA Recent Past, Current & Future Analysis for Mycoplasma Testing by Offering - Assays, Kits & Reagents, Services and Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Mycoplasma Testing by Offering - Assays, Kits & Reagents, Services and Instruments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: USA 15-Year Perspective for Mycoplasma Testing by Offering - Percentage Breakdown of Value Sales for Assays, Kits & Reagents, Services and Instruments for the Years 2015, 2025 & 2030
    • TABLE 41: USA Recent Past, Current & Future Analysis for Mycoplasma Testing by Technique - Nucleic Acid Testing (NAT), ELISA, Staining and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Mycoplasma Testing by Technique - Nucleic Acid Testing (NAT), ELISA, Staining and Other Techniques Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: USA 15-Year Perspective for Mycoplasma Testing by Technique - Percentage Breakdown of Value Sales for Nucleic Acid Testing (NAT), ELISA, Staining and Other Techniques for the Years 2015, 2025 & 2030
    • TABLE 44: USA Recent Past, Current & Future Analysis for Mycoplasma Testing by Application - Cell Line Testing, End-of-Production Cell Testing, Virus Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: USA Historic Review for Mycoplasma Testing by Application - Cell Line Testing, End-of-Production Cell Testing, Virus Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: USA 15-Year Perspective for Mycoplasma Testing by Application - Percentage Breakdown of Value Sales for Cell Line Testing, End-of-Production Cell Testing, Virus Testing and Other Applications for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Mycoplasma Testing by Offering - Assays, Kits & Reagents, Services and Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Mycoplasma Testing by Offering - Assays, Kits & Reagents, Services and Instruments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: Canada 15-Year Perspective for Mycoplasma Testing by Offering - Percentage Breakdown of Value Sales for Assays, Kits & Reagents, Services and Instruments for the Years 2015, 2025 & 2030
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Mycoplasma Testing by Technique - Nucleic Acid Testing (NAT), ELISA, Staining and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for Mycoplasma Testing by Technique - Nucleic Acid Testing (NAT), ELISA, Staining and Other Techniques Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: Canada 15-Year Perspective for Mycoplasma Testing by Technique - Percentage Breakdown of Value Sales for Nucleic Acid Testing (NAT), ELISA, Staining and Other Techniques for the Years 2015, 2025 & 2030
    • TABLE 53: Canada Recent Past, Current & Future Analysis for Mycoplasma Testing by Application - Cell Line Testing, End-of-Production Cell Testing, Virus Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Canada Historic Review for Mycoplasma Testing by Application - Cell Line Testing, End-of-Production Cell Testing, Virus Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Canada 15-Year Perspective for Mycoplasma Testing by Application - Percentage Breakdown of Value Sales for Cell Line Testing, End-of-Production Cell Testing, Virus Testing and Other Applications for the Years 2015, 2025 & 2030
  • JAPAN
    • Mycoplasma Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Mycoplasma Testing by Offering - Assays, Kits & Reagents, Services and Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Japan Historic Review for Mycoplasma Testing by Offering - Assays, Kits & Reagents, Services and Instruments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: Japan 15-Year Perspective for Mycoplasma Testing by Offering - Percentage Breakdown of Value Sales for Assays, Kits & Reagents, Services and Instruments for the Years 2015, 2025 & 2030
    • TABLE 59: Japan Recent Past, Current & Future Analysis for Mycoplasma Testing by Technique - Nucleic Acid Testing (NAT), ELISA, Staining and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Japan Historic Review for Mycoplasma Testing by Technique - Nucleic Acid Testing (NAT), ELISA, Staining and Other Techniques Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: Japan 15-Year Perspective for Mycoplasma Testing by Technique - Percentage Breakdown of Value Sales for Nucleic Acid Testing (NAT), ELISA, Staining and Other Techniques for the Years 2015, 2025 & 2030
    • TABLE 62: Japan Recent Past, Current & Future Analysis for Mycoplasma Testing by Application - Cell Line Testing, End-of-Production Cell Testing, Virus Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Japan Historic Review for Mycoplasma Testing by Application - Cell Line Testing, End-of-Production Cell Testing, Virus Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: Japan 15-Year Perspective for Mycoplasma Testing by Application - Percentage Breakdown of Value Sales for Cell Line Testing, End-of-Production Cell Testing, Virus Testing and Other Applications for the Years 2015, 2025 & 2030
  • CHINA
    • Mycoplasma Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 65: China Recent Past, Current & Future Analysis for Mycoplasma Testing by Offering - Assays, Kits & Reagents, Services and Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: China Historic Review for Mycoplasma Testing by Offering - Assays, Kits & Reagents, Services and Instruments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: China 15-Year Perspective for Mycoplasma Testing by Offering - Percentage Breakdown of Value Sales for Assays, Kits & Reagents, Services and Instruments for the Years 2015, 2025 & 2030
    • TABLE 68: China Recent Past, Current & Future Analysis for Mycoplasma Testing by Technique - Nucleic Acid Testing (NAT), ELISA, Staining and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: China Historic Review for Mycoplasma Testing by Technique - Nucleic Acid Testing (NAT), ELISA, Staining and Other Techniques Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: China 15-Year Perspective for Mycoplasma Testing by Technique - Percentage Breakdown of Value Sales for Nucleic Acid Testing (NAT), ELISA, Staining and Other Techniques for the Years 2015, 2025 & 2030
    • TABLE 71: China Recent Past, Current & Future Analysis for Mycoplasma Testing by Application - Cell Line Testing, End-of-Production Cell Testing, Virus Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: China Historic Review for Mycoplasma Testing by Application - Cell Line Testing, End-of-Production Cell Testing, Virus Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: China 15-Year Perspective for Mycoplasma Testing by Application - Percentage Breakdown of Value Sales for Cell Line Testing, End-of-Production Cell Testing, Virus Testing and Other Applications for the Years 2015, 2025 & 2030
  • EUROPE
    • Mycoplasma Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Mycoplasma Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Mycoplasma Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: Europe 15-Year Perspective for Mycoplasma Testing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Mycoplasma Testing by Offering - Assays, Kits & Reagents, Services and Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Mycoplasma Testing by Offering - Assays, Kits & Reagents, Services and Instruments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: Europe 15-Year Perspective for Mycoplasma Testing by Offering - Percentage Breakdown of Value Sales for Assays, Kits & Reagents, Services and Instruments for the Years 2015, 2025 & 2030
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Mycoplasma Testing by Technique - Nucleic Acid Testing (NAT), ELISA, Staining and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Europe Historic Review for Mycoplasma Testing by Technique - Nucleic Acid Testing (NAT), ELISA, Staining and Other Techniques Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: Europe 15-Year Perspective for Mycoplasma Testing by Technique - Percentage Breakdown of Value Sales for Nucleic Acid Testing (NAT), ELISA, Staining and Other Techniques for the Years 2015, 2025 & 2030
    • TABLE 83: Europe Recent Past, Current & Future Analysis for Mycoplasma Testing by Application - Cell Line Testing, End-of-Production Cell Testing, Virus Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Europe Historic Review for Mycoplasma Testing by Application - Cell Line Testing, End-of-Production Cell Testing, Virus Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: Europe 15-Year Perspective for Mycoplasma Testing by Application - Percentage Breakdown of Value Sales for Cell Line Testing, End-of-Production Cell Testing, Virus Testing and Other Applications for the Years 2015, 2025 & 2030
  • FRANCE
    • Mycoplasma Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 86: France Recent Past, Current & Future Analysis for Mycoplasma Testing by Offering - Assays, Kits & Reagents, Services and Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: France Historic Review for Mycoplasma Testing by Offering - Assays, Kits & Reagents, Services and Instruments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: France 15-Year Perspective for Mycoplasma Testing by Offering - Percentage Breakdown of Value Sales for Assays, Kits & Reagents, Services and Instruments for the Years 2015, 2025 & 2030
    • TABLE 89: France Recent Past, Current & Future Analysis for Mycoplasma Testing by Technique - Nucleic Acid Testing (NAT), ELISA, Staining and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: France Historic Review for Mycoplasma Testing by Technique - Nucleic Acid Testing (NAT), ELISA, Staining and Other Techniques Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: France 15-Year Perspective for Mycoplasma Testing by Technique - Percentage Breakdown of Value Sales for Nucleic Acid Testing (NAT), ELISA, Staining and Other Techniques for the Years 2015, 2025 & 2030
    • TABLE 92: France Recent Past, Current & Future Analysis for Mycoplasma Testing by Application - Cell Line Testing, End-of-Production Cell Testing, Virus Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: France Historic Review for Mycoplasma Testing by Application - Cell Line Testing, End-of-Production Cell Testing, Virus Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: France 15-Year Perspective for Mycoplasma Testing by Application - Percentage Breakdown of Value Sales for Cell Line Testing, End-of-Production Cell Testing, Virus Testing and Other Applications for the Years 2015, 2025 & 2030
  • GERMANY
    • Mycoplasma Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 95: Germany Recent Past, Current & Future Analysis for Mycoplasma Testing by Offering - Assays, Kits & Reagents, Services and Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Germany Historic Review for Mycoplasma Testing by Offering - Assays, Kits & Reagents, Services and Instruments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Germany 15-Year Perspective for Mycoplasma Testing by Offering - Percentage Breakdown of Value Sales for Assays, Kits & Reagents, Services and Instruments for the Years 2015, 2025 & 2030
    • TABLE 98: Germany Recent Past, Current & Future Analysis for Mycoplasma Testing by Technique - Nucleic Acid Testing (NAT), ELISA, Staining and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Germany Historic Review for Mycoplasma Testing by Technique - Nucleic Acid Testing (NAT), ELISA, Staining and Other Techniques Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Germany 15-Year Perspective for Mycoplasma Testing by Technique - Percentage Breakdown of Value Sales for Nucleic Acid Testing (NAT), ELISA, Staining and Other Techniques for the Years 2015, 2025 & 2030
    • TABLE 101: Germany Recent Past, Current & Future Analysis for Mycoplasma Testing by Application - Cell Line Testing, End-of-Production Cell Testing, Virus Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Germany Historic Review for Mycoplasma Testing by Application - Cell Line Testing, End-of-Production Cell Testing, Virus Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Germany 15-Year Perspective for Mycoplasma Testing by Application - Percentage Breakdown of Value Sales for Cell Line Testing, End-of-Production Cell Testing, Virus Testing and Other Applications for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 104: Italy Recent Past, Current & Future Analysis for Mycoplasma Testing by Offering - Assays, Kits & Reagents, Services and Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Italy Historic Review for Mycoplasma Testing by Offering - Assays, Kits & Reagents, Services and Instruments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: Italy 15-Year Perspective for Mycoplasma Testing by Offering - Percentage Breakdown of Value Sales for Assays, Kits & Reagents, Services and Instruments for the Years 2015, 2025 & 2030
    • TABLE 107: Italy Recent Past, Current & Future Analysis for Mycoplasma Testing by Technique - Nucleic Acid Testing (NAT), ELISA, Staining and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Italy Historic Review for Mycoplasma Testing by Technique - Nucleic Acid Testing (NAT), ELISA, Staining and Other Techniques Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: Italy 15-Year Perspective for Mycoplasma Testing by Technique - Percentage Breakdown of Value Sales for Nucleic Acid Testing (NAT), ELISA, Staining and Other Techniques for the Years 2015, 2025 & 2030
    • TABLE 110: Italy Recent Past, Current & Future Analysis for Mycoplasma Testing by Application - Cell Line Testing, End-of-Production Cell Testing, Virus Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Italy Historic Review for Mycoplasma Testing by Application - Cell Line Testing, End-of-Production Cell Testing, Virus Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: Italy 15-Year Perspective for Mycoplasma Testing by Application - Percentage Breakdown of Value Sales for Cell Line Testing, End-of-Production Cell Testing, Virus Testing and Other Applications for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Mycoplasma Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 113: UK Recent Past, Current & Future Analysis for Mycoplasma Testing by Offering - Assays, Kits & Reagents, Services and Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: UK Historic Review for Mycoplasma Testing by Offering - Assays, Kits & Reagents, Services and Instruments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: UK 15-Year Perspective for Mycoplasma Testing by Offering - Percentage Breakdown of Value Sales for Assays, Kits & Reagents, Services and Instruments for the Years 2015, 2025 & 2030
    • TABLE 116: UK Recent Past, Current & Future Analysis for Mycoplasma Testing by Technique - Nucleic Acid Testing (NAT), ELISA, Staining and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: UK Historic Review for Mycoplasma Testing by Technique - Nucleic Acid Testing (NAT), ELISA, Staining and Other Techniques Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: UK 15-Year Perspective for Mycoplasma Testing by Technique - Percentage Breakdown of Value Sales for Nucleic Acid Testing (NAT), ELISA, Staining and Other Techniques for the Years 2015, 2025 & 2030
    • TABLE 119: UK Recent Past, Current & Future Analysis for Mycoplasma Testing by Application - Cell Line Testing, End-of-Production Cell Testing, Virus Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: UK Historic Review for Mycoplasma Testing by Application - Cell Line Testing, End-of-Production Cell Testing, Virus Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: UK 15-Year Perspective for Mycoplasma Testing by Application - Percentage Breakdown of Value Sales for Cell Line Testing, End-of-Production Cell Testing, Virus Testing and Other Applications for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 122: Spain Recent Past, Current & Future Analysis for Mycoplasma Testing by Offering - Assays, Kits & Reagents, Services and Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Spain Historic Review for Mycoplasma Testing by Offering - Assays, Kits & Reagents, Services and Instruments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: Spain 15-Year Perspective for Mycoplasma Testing by Offering - Percentage Breakdown of Value Sales for Assays, Kits & Reagents, Services and Instruments for the Years 2015, 2025 & 2030
    • TABLE 125: Spain Recent Past, Current & Future Analysis for Mycoplasma Testing by Technique - Nucleic Acid Testing (NAT), ELISA, Staining and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Spain Historic Review for Mycoplasma Testing by Technique - Nucleic Acid Testing (NAT), ELISA, Staining and Other Techniques Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: Spain 15-Year Perspective for Mycoplasma Testing by Technique - Percentage Breakdown of Value Sales for Nucleic Acid Testing (NAT), ELISA, Staining and Other Techniques for the Years 2015, 2025 & 2030
    • TABLE 128: Spain Recent Past, Current & Future Analysis for Mycoplasma Testing by Application - Cell Line Testing, End-of-Production Cell Testing, Virus Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Spain Historic Review for Mycoplasma Testing by Application - Cell Line Testing, End-of-Production Cell Testing, Virus Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: Spain 15-Year Perspective for Mycoplasma Testing by Application - Percentage Breakdown of Value Sales for Cell Line Testing, End-of-Production Cell Testing, Virus Testing and Other Applications for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 131: Russia Recent Past, Current & Future Analysis for Mycoplasma Testing by Offering - Assays, Kits & Reagents, Services and Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Russia Historic Review for Mycoplasma Testing by Offering - Assays, Kits & Reagents, Services and Instruments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: Russia 15-Year Perspective for Mycoplasma Testing by Offering - Percentage Breakdown of Value Sales for Assays, Kits & Reagents, Services and Instruments for the Years 2015, 2025 & 2030
    • TABLE 134: Russia Recent Past, Current & Future Analysis for Mycoplasma Testing by Technique - Nucleic Acid Testing (NAT), ELISA, Staining and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Russia Historic Review for Mycoplasma Testing by Technique - Nucleic Acid Testing (NAT), ELISA, Staining and Other Techniques Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: Russia 15-Year Perspective for Mycoplasma Testing by Technique - Percentage Breakdown of Value Sales for Nucleic Acid Testing (NAT), ELISA, Staining and Other Techniques for the Years 2015, 2025 & 2030
    • TABLE 137: Russia Recent Past, Current & Future Analysis for Mycoplasma Testing by Application - Cell Line Testing, End-of-Production Cell Testing, Virus Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Russia Historic Review for Mycoplasma Testing by Application - Cell Line Testing, End-of-Production Cell Testing, Virus Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: Russia 15-Year Perspective for Mycoplasma Testing by Application - Percentage Breakdown of Value Sales for Cell Line Testing, End-of-Production Cell Testing, Virus Testing and Other Applications for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for Mycoplasma Testing by Offering - Assays, Kits & Reagents, Services and Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Rest of Europe Historic Review for Mycoplasma Testing by Offering - Assays, Kits & Reagents, Services and Instruments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 142: Rest of Europe 15-Year Perspective for Mycoplasma Testing by Offering - Percentage Breakdown of Value Sales for Assays, Kits & Reagents, Services and Instruments for the Years 2015, 2025 & 2030
    • TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for Mycoplasma Testing by Technique - Nucleic Acid Testing (NAT), ELISA, Staining and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Rest of Europe Historic Review for Mycoplasma Testing by Technique - Nucleic Acid Testing (NAT), ELISA, Staining and Other Techniques Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 145: Rest of Europe 15-Year Perspective for Mycoplasma Testing by Technique - Percentage Breakdown of Value Sales for Nucleic Acid Testing (NAT), ELISA, Staining and Other Techniques for the Years 2015, 2025 & 2030
    • TABLE 146: Rest of Europe Recent Past, Current & Future Analysis for Mycoplasma Testing by Application - Cell Line Testing, End-of-Production Cell Testing, Virus Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Rest of Europe Historic Review for Mycoplasma Testing by Application - Cell Line Testing, End-of-Production Cell Testing, Virus Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 148: Rest of Europe 15-Year Perspective for Mycoplasma Testing by Application - Percentage Breakdown of Value Sales for Cell Line Testing, End-of-Production Cell Testing, Virus Testing and Other Applications for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Mycoplasma Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Mycoplasma Testing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 150: Asia-Pacific Historic Review for Mycoplasma Testing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 151: Asia-Pacific 15-Year Perspective for Mycoplasma Testing by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Mycoplasma Testing by Offering - Assays, Kits & Reagents, Services and Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Asia-Pacific Historic Review for Mycoplasma Testing by Offering - Assays, Kits & Reagents, Services and Instruments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 154: Asia-Pacific 15-Year Perspective for Mycoplasma Testing by Offering - Percentage Breakdown of Value Sales for Assays, Kits & Reagents, Services and Instruments for the Years 2015, 2025 & 2030
    • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Mycoplasma Testing by Technique - Nucleic Acid Testing (NAT), ELISA, Staining and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Asia-Pacific Historic Review for Mycoplasma Testing by Technique - Nucleic Acid Testing (NAT), ELISA, Staining and Other Techniques Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 157: Asia-Pacific 15-Year Perspective for Mycoplasma Testing by Technique - Percentage Breakdown of Value Sales for Nucleic Acid Testing (NAT), ELISA, Staining and Other Techniques for the Years 2015, 2025 & 2030
    • TABLE 158: Asia-Pacific Recent Past, Current & Future Analysis for Mycoplasma Testing by Application - Cell Line Testing, End-of-Production Cell Testing, Virus Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Asia-Pacific Historic Review for Mycoplasma Testing by Application - Cell Line Testing, End-of-Production Cell Testing, Virus Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 160: Asia-Pacific 15-Year Perspective for Mycoplasma Testing by Application - Percentage Breakdown of Value Sales for Cell Line Testing, End-of-Production Cell Testing, Virus Testing and Other Applications for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Mycoplasma Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 161: Australia Recent Past, Current & Future Analysis for Mycoplasma Testing by Offering - Assays, Kits & Reagents, Services and Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Australia Historic Review for Mycoplasma Testing by Offering - Assays, Kits & Reagents, Services and Instruments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 163: Australia 15-Year Perspective for Mycoplasma Testing by Offering - Percentage Breakdown of Value Sales for Assays, Kits & Reagents, Services and Instruments for the Years 2015, 2025 & 2030
    • TABLE 164: Australia Recent Past, Current & Future Analysis for Mycoplasma Testing by Technique - Nucleic Acid Testing (NAT), ELISA, Staining and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Australia Historic Review for Mycoplasma Testing by Technique - Nucleic Acid Testing (NAT), ELISA, Staining and Other Techniques Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 166: Australia 15-Year Perspective for Mycoplasma Testing by Technique - Percentage Breakdown of Value Sales for Nucleic Acid Testing (NAT), ELISA, Staining and Other Techniques for the Years 2015, 2025 & 2030
    • TABLE 167: Australia Recent Past, Current & Future Analysis for Mycoplasma Testing by Application - Cell Line Testing, End-of-Production Cell Testing, Virus Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Australia Historic Review for Mycoplasma Testing by Application - Cell Line Testing, End-of-Production Cell Testing, Virus Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 169: Australia 15-Year Perspective for Mycoplasma Testing by Application - Percentage Breakdown of Value Sales for Cell Line Testing, End-of-Production Cell Testing, Virus Testing and Other Applications for the Years 2015, 2025 & 2030
  • INDIA
    • Mycoplasma Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 170: India Recent Past, Current & Future Analysis for Mycoplasma Testing by Offering - Assays, Kits & Reagents, Services and Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: India Historic Review for Mycoplasma Testing by Offering - Assays, Kits & Reagents, Services and Instruments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 172: India 15-Year Perspective for Mycoplasma Testing by Offering - Percentage Breakdown of Value Sales for Assays, Kits & Reagents, Services and Instruments for the Years 2015, 2025 & 2030
    • TABLE 173: India Recent Past, Current & Future Analysis for Mycoplasma Testing by Technique - Nucleic Acid Testing (NAT), ELISA, Staining and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: India Historic Review for Mycoplasma Testing by Technique - Nucleic Acid Testing (NAT), ELISA, Staining and Other Techniques Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 175: India 15-Year Perspective for Mycoplasma Testing by Technique - Percentage Breakdown of Value Sales for Nucleic Acid Testing (NAT), ELISA, Staining and Other Techniques for the Years 2015, 2025 & 2030
    • TABLE 176: India Recent Past, Current & Future Analysis for Mycoplasma Testing by Application - Cell Line Testing, End-of-Production Cell Testing, Virus Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: India Historic Review for Mycoplasma Testing by Application - Cell Line Testing, End-of-Production Cell Testing, Virus Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 178: India 15-Year Perspective for Mycoplasma Testing by Application - Percentage Breakdown of Value Sales for Cell Line Testing, End-of-Production Cell Testing, Virus Testing and Other Applications for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 179: South Korea Recent Past, Current & Future Analysis for Mycoplasma Testing by Offering - Assays, Kits & Reagents, Services and Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: South Korea Historic Review for Mycoplasma Testing by Offering - Assays, Kits & Reagents, Services and Instruments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 181: South Korea 15-Year Perspective for Mycoplasma Testing by Offering - Percentage Breakdown of Value Sales for Assays, Kits & Reagents, Services and Instruments for the Years 2015, 2025 & 2030
    • TABLE 182: South Korea Recent Past, Current & Future Analysis for Mycoplasma Testing by Technique - Nucleic Acid Testing (NAT), ELISA, Staining and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: South Korea Historic Review for Mycoplasma Testing by Technique - Nucleic Acid Testing (NAT), ELISA, Staining and Other Techniques Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 184: South Korea 15-Year Perspective for Mycoplasma Testing by Technique - Percentage Breakdown of Value Sales for Nucleic Acid Testing (NAT), ELISA, Staining and Other Techniques for the Years 2015, 2025 & 2030
    • TABLE 185: South Korea Recent Past, Current & Future Analysis for Mycoplasma Testing by Application - Cell Line Testing, End-of-Production Cell Testing, Virus Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: South Korea Historic Review for Mycoplasma Testing by Application - Cell Line Testing, End-of-Production Cell Testing, Virus Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 187: South Korea 15-Year Perspective for Mycoplasma Testing by Application - Percentage Breakdown of Value Sales for Cell Line Testing, End-of-Production Cell Testing, Virus Testing and Other Applications for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 188: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Mycoplasma Testing by Offering - Assays, Kits & Reagents, Services and Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Rest of Asia-Pacific Historic Review for Mycoplasma Testing by Offering - Assays, Kits & Reagents, Services and Instruments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 190: Rest of Asia-Pacific 15-Year Perspective for Mycoplasma Testing by Offering - Percentage Breakdown of Value Sales for Assays, Kits & Reagents, Services and Instruments for the Years 2015, 2025 & 2030
    • TABLE 191: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Mycoplasma Testing by Technique - Nucleic Acid Testing (NAT), ELISA, Staining and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Rest of Asia-Pacific Historic Review for Mycoplasma Testing by Technique - Nucleic Acid Testing (NAT), ELISA, Staining and Other Techniques Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 193: Rest of Asia-Pacific 15-Year Perspective for Mycoplasma Testing by Technique - Percentage Breakdown of Value Sales for Nucleic Acid Testing (NAT), ELISA, Staining and Other Techniques for the Years 2015, 2025 & 2030
    • TABLE 194: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Mycoplasma Testing by Application - Cell Line Testing, End-of-Production Cell Testing, Virus Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Rest of Asia-Pacific Historic Review for Mycoplasma Testing by Application - Cell Line Testing, End-of-Production Cell Testing, Virus Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 196: Rest of Asia-Pacific 15-Year Perspective for Mycoplasma Testing by Application - Percentage Breakdown of Value Sales for Cell Line Testing, End-of-Production Cell Testing, Virus Testing and Other Applications for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Mycoplasma Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 197: Latin America Recent Past, Current & Future Analysis for Mycoplasma Testing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 198: Latin America Historic Review for Mycoplasma Testing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 199: Latin America 15-Year Perspective for Mycoplasma Testing by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 200: Latin America Recent Past, Current & Future Analysis for Mycoplasma Testing by Offering - Assays, Kits & Reagents, Services and Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Latin America Historic Review for Mycoplasma Testing by Offering - Assays, Kits & Reagents, Services and Instruments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 202: Latin America 15-Year Perspective for Mycoplasma Testing by Offering - Percentage Breakdown of Value Sales for Assays, Kits & Reagents, Services and Instruments for the Years 2015, 2025 & 2030
    • TABLE 203: Latin America Recent Past, Current & Future Analysis for Mycoplasma Testing by Technique - Nucleic Acid Testing (NAT), ELISA, Staining and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Latin America Historic Review for Mycoplasma Testing by Technique - Nucleic Acid Testing (NAT), ELISA, Staining and Other Techniques Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 205: Latin America 15-Year Perspective for Mycoplasma Testing by Technique - Percentage Breakdown of Value Sales for Nucleic Acid Testing (NAT), ELISA, Staining and Other Techniques for the Years 2015, 2025 & 2030
    • TABLE 206: Latin America Recent Past, Current & Future Analysis for Mycoplasma Testing by Application - Cell Line Testing, End-of-Production Cell Testing, Virus Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Latin America Historic Review for Mycoplasma Testing by Application - Cell Line Testing, End-of-Production Cell Testing, Virus Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 208: Latin America 15-Year Perspective for Mycoplasma Testing by Application - Percentage Breakdown of Value Sales for Cell Line Testing, End-of-Production Cell Testing, Virus Testing and Other Applications for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 209: Argentina Recent Past, Current & Future Analysis for Mycoplasma Testing by Offering - Assays, Kits & Reagents, Services and Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Argentina Historic Review for Mycoplasma Testing by Offering - Assays, Kits & Reagents, Services and Instruments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 211: Argentina 15-Year Perspective for Mycoplasma Testing by Offering - Percentage Breakdown of Value Sales for Assays, Kits & Reagents, Services and Instruments for the Years 2015, 2025 & 2030
    • TABLE 212: Argentina Recent Past, Current & Future Analysis for Mycoplasma Testing by Technique - Nucleic Acid Testing (NAT), ELISA, Staining and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Argentina Historic Review for Mycoplasma Testing by Technique - Nucleic Acid Testing (NAT), ELISA, Staining and Other Techniques Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 214: Argentina 15-Year Perspective for Mycoplasma Testing by Technique - Percentage Breakdown of Value Sales for Nucleic Acid Testing (NAT), ELISA, Staining and Other Techniques for the Years 2015, 2025 & 2030
    • TABLE 215: Argentina Recent Past, Current & Future Analysis for Mycoplasma Testing by Application - Cell Line Testing, End-of-Production Cell Testing, Virus Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Argentina Historic Review for Mycoplasma Testing by Application - Cell Line Testing, End-of-Production Cell Testing, Virus Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 217: Argentina 15-Year Perspective for Mycoplasma Testing by Application - Percentage Breakdown of Value Sales for Cell Line Testing, End-of-Production Cell Testing, Virus Testing and Other Applications for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 218: Brazil Recent Past, Current & Future Analysis for Mycoplasma Testing by Offering - Assays, Kits & Reagents, Services and Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Brazil Historic Review for Mycoplasma Testing by Offering - Assays, Kits & Reagents, Services and Instruments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 220: Brazil 15-Year Perspective for Mycoplasma Testing by Offering - Percentage Breakdown of Value Sales for Assays, Kits & Reagents, Services and Instruments for the Years 2015, 2025 & 2030
    • TABLE 221: Brazil Recent Past, Current & Future Analysis for Mycoplasma Testing by Technique - Nucleic Acid Testing (NAT), ELISA, Staining and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Brazil Historic Review for Mycoplasma Testing by Technique - Nucleic Acid Testing (NAT), ELISA, Staining and Other Techniques Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 223: Brazil 15-Year Perspective for Mycoplasma Testing by Technique - Percentage Breakdown of Value Sales for Nucleic Acid Testing (NAT), ELISA, Staining and Other Techniques for the Years 2015, 2025 & 2030
    • TABLE 224: Brazil Recent Past, Current & Future Analysis for Mycoplasma Testing by Application - Cell Line Testing, End-of-Production Cell Testing, Virus Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Brazil Historic Review for Mycoplasma Testing by Application - Cell Line Testing, End-of-Production Cell Testing, Virus Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 226: Brazil 15-Year Perspective for Mycoplasma Testing by Application - Percentage Breakdown of Value Sales for Cell Line Testing, End-of-Production Cell Testing, Virus Testing and Other Applications for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 227: Mexico Recent Past, Current & Future Analysis for Mycoplasma Testing by Offering - Assays, Kits & Reagents, Services and Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 228: Mexico Historic Review for Mycoplasma Testing by Offering - Assays, Kits & Reagents, Services and Instruments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 229: Mexico 15-Year Perspective for Mycoplasma Testing by Offering - Percentage Breakdown of Value Sales for Assays, Kits & Reagents, Services and Instruments for the Years 2015, 2025 & 2030
    • TABLE 230: Mexico Recent Past, Current & Future Analysis for Mycoplasma Testing by Technique - Nucleic Acid Testing (NAT), ELISA, Staining and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 231: Mexico Historic Review for Mycoplasma Testing by Technique - Nucleic Acid Testing (NAT), ELISA, Staining and Other Techniques Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 232: Mexico 15-Year Perspective for Mycoplasma Testing by Technique - Percentage Breakdown of Value Sales for Nucleic Acid Testing (NAT), ELISA, Staining and Other Techniques for the Years 2015, 2025 & 2030
    • TABLE 233: Mexico Recent Past, Current & Future Analysis for Mycoplasma Testing by Application - Cell Line Testing, End-of-Production Cell Testing, Virus Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 234: Mexico Historic Review for Mycoplasma Testing by Application - Cell Line Testing, End-of-Production Cell Testing, Virus Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 235: Mexico 15-Year Perspective for Mycoplasma Testing by Application - Percentage Breakdown of Value Sales for Cell Line Testing, End-of-Production Cell Testing, Virus Testing and Other Applications for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 236: Rest of Latin America Recent Past, Current & Future Analysis for Mycoplasma Testing by Offering - Assays, Kits & Reagents, Services and Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 237: Rest of Latin America Historic Review for Mycoplasma Testing by Offering - Assays, Kits & Reagents, Services and Instruments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 238: Rest of Latin America 15-Year Perspective for Mycoplasma Testing by Offering - Percentage Breakdown of Value Sales for Assays, Kits & Reagents, Services and Instruments for the Years 2015, 2025 & 2030
    • TABLE 239: Rest of Latin America Recent Past, Current & Future Analysis for Mycoplasma Testing by Technique - Nucleic Acid Testing (NAT), ELISA, Staining and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 240: Rest of Latin America Historic Review for Mycoplasma Testing by Technique - Nucleic Acid Testing (NAT), ELISA, Staining and Other Techniques Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 241: Rest of Latin America 15-Year Perspective for Mycoplasma Testing by Technique - Percentage Breakdown of Value Sales for Nucleic Acid Testing (NAT), ELISA, Staining and Other Techniques for the Years 2015, 2025 & 2030
    • TABLE 242: Rest of Latin America Recent Past, Current & Future Analysis for Mycoplasma Testing by Application - Cell Line Testing, End-of-Production Cell Testing, Virus Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 243: Rest of Latin America Historic Review for Mycoplasma Testing by Application - Cell Line Testing, End-of-Production Cell Testing, Virus Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 244: Rest of Latin America 15-Year Perspective for Mycoplasma Testing by Application - Percentage Breakdown of Value Sales for Cell Line Testing, End-of-Production Cell Testing, Virus Testing and Other Applications for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Mycoplasma Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 245: Middle East Recent Past, Current & Future Analysis for Mycoplasma Testing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 246: Middle East Historic Review for Mycoplasma Testing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 247: Middle East 15-Year Perspective for Mycoplasma Testing by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 248: Middle East Recent Past, Current & Future Analysis for Mycoplasma Testing by Offering - Assays, Kits & Reagents, Services and Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 249: Middle East Historic Review for Mycoplasma Testing by Offering - Assays, Kits & Reagents, Services and Instruments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 250: Middle East 15-Year Perspective for Mycoplasma Testing by Offering - Percentage Breakdown of Value Sales for Assays, Kits & Reagents, Services and Instruments for the Years 2015, 2025 & 2030
    • TABLE 251: Middle East Recent Past, Current & Future Analysis for Mycoplasma Testing by Technique - Nucleic Acid Testing (NAT), ELISA, Staining and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 252: Middle East Historic Review for Mycoplasma Testing by Technique - Nucleic Acid Testing (NAT), ELISA, Staining and Other Techniques Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 253: Middle East 15-Year Perspective for Mycoplasma Testing by Technique - Percentage Breakdown of Value Sales for Nucleic Acid Testing (NAT), ELISA, Staining and Other Techniques for the Years 2015, 2025 & 2030
    • TABLE 254: Middle East Recent Past, Current & Future Analysis for Mycoplasma Testing by Application - Cell Line Testing, End-of-Production Cell Testing, Virus Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 255: Middle East Historic Review for Mycoplasma Testing by Application - Cell Line Testing, End-of-Production Cell Testing, Virus Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 256: Middle East 15-Year Perspective for Mycoplasma Testing by Application - Percentage Breakdown of Value Sales for Cell Line Testing, End-of-Production Cell Testing, Virus Testing and Other Applications for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 257: Iran Recent Past, Current & Future Analysis for Mycoplasma Testing by Offering - Assays, Kits & Reagents, Services and Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 258: Iran Historic Review for Mycoplasma Testing by Offering - Assays, Kits & Reagents, Services and Instruments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 259: Iran 15-Year Perspective for Mycoplasma Testing by Offering - Percentage Breakdown of Value Sales for Assays, Kits & Reagents, Services and Instruments for the Years 2015, 2025 & 2030
    • TABLE 260: Iran Recent Past, Current & Future Analysis for Mycoplasma Testing by Technique - Nucleic Acid Testing (NAT), ELISA, Staining and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Iran Historic Review for Mycoplasma Testing by Technique - Nucleic Acid Testing (NAT), ELISA, Staining and Other Techniques Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 262: Iran 15-Year Perspective for Mycoplasma Testing by Technique - Percentage Breakdown of Value Sales for Nucleic Acid Testing (NAT), ELISA, Staining and Other Techniques for the Years 2015, 2025 & 2030
    • TABLE 263: Iran Recent Past, Current & Future Analysis for Mycoplasma Testing by Application - Cell Line Testing, End-of-Production Cell Testing, Virus Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Iran Historic Review for Mycoplasma Testing by Application - Cell Line Testing, End-of-Production Cell Testing, Virus Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 265: Iran 15-Year Perspective for Mycoplasma Testing by Application - Percentage Breakdown of Value Sales for Cell Line Testing, End-of-Production Cell Testing, Virus Testing and Other Applications for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 266: Israel Recent Past, Current & Future Analysis for Mycoplasma Testing by Offering - Assays, Kits & Reagents, Services and Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Israel Historic Review for Mycoplasma Testing by Offering - Assays, Kits & Reagents, Services and Instruments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 268: Israel 15-Year Perspective for Mycoplasma Testing by Offering - Percentage Breakdown of Value Sales for Assays, Kits & Reagents, Services and Instruments for the Years 2015, 2025 & 2030
    • TABLE 269: Israel Recent Past, Current & Future Analysis for Mycoplasma Testing by Technique - Nucleic Acid Testing (NAT), ELISA, Staining and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Israel Historic Review for Mycoplasma Testing by Technique - Nucleic Acid Testing (NAT), ELISA, Staining and Other Techniques Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 271: Israel 15-Year Perspective for Mycoplasma Testing by Technique - Percentage Breakdown of Value Sales for Nucleic Acid Testing (NAT), ELISA, Staining and Other Techniques for the Years 2015, 2025 & 2030
    • TABLE 272: Israel Recent Past, Current & Future Analysis for Mycoplasma Testing by Application - Cell Line Testing, End-of-Production Cell Testing, Virus Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 273: Israel Historic Review for Mycoplasma Testing by Application - Cell Line Testing, End-of-Production Cell Testing, Virus Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 274: Israel 15-Year Perspective for Mycoplasma Testing by Application - Percentage Breakdown of Value Sales for Cell Line Testing, End-of-Production Cell Testing, Virus Testing and Other Applications for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 275: Saudi Arabia Recent Past, Current & Future Analysis for Mycoplasma Testing by Offering - Assays, Kits & Reagents, Services and Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 276: Saudi Arabia Historic Review for Mycoplasma Testing by Offering - Assays, Kits & Reagents, Services and Instruments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 277: Saudi Arabia 15-Year Perspective for Mycoplasma Testing by Offering - Percentage Breakdown of Value Sales for Assays, Kits & Reagents, Services and Instruments for the Years 2015, 2025 & 2030
    • TABLE 278: Saudi Arabia Recent Past, Current & Future Analysis for Mycoplasma Testing by Technique - Nucleic Acid Testing (NAT), ELISA, Staining and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 279: Saudi Arabia Historic Review for Mycoplasma Testing by Technique - Nucleic Acid Testing (NAT), ELISA, Staining and Other Techniques Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 280: Saudi Arabia 15-Year Perspective for Mycoplasma Testing by Technique - Percentage Breakdown of Value Sales for Nucleic Acid Testing (NAT), ELISA, Staining and Other Techniques for the Years 2015, 2025 & 2030
    • TABLE 281: Saudi Arabia Recent Past, Current & Future Analysis for Mycoplasma Testing by Application - Cell Line Testing, End-of-Production Cell Testing, Virus Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 282: Saudi Arabia Historic Review for Mycoplasma Testing by Application - Cell Line Testing, End-of-Production Cell Testing, Virus Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 283: Saudi Arabia 15-Year Perspective for Mycoplasma Testing by Application - Percentage Breakdown of Value Sales for Cell Line Testing, End-of-Production Cell Testing, Virus Testing and Other Applications for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 284: UAE Recent Past, Current & Future Analysis for Mycoplasma Testing by Offering - Assays, Kits & Reagents, Services and Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 285: UAE Historic Review for Mycoplasma Testing by Offering - Assays, Kits & Reagents, Services and Instruments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 286: UAE 15-Year Perspective for Mycoplasma Testing by Offering - Percentage Breakdown of Value Sales for Assays, Kits & Reagents, Services and Instruments for the Years 2015, 2025 & 2030
    • TABLE 287: UAE Recent Past, Current & Future Analysis for Mycoplasma Testing by Technique - Nucleic Acid Testing (NAT), ELISA, Staining and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 288: UAE Historic Review for Mycoplasma Testing by Technique - Nucleic Acid Testing (NAT), ELISA, Staining and Other Techniques Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 289: UAE 15-Year Perspective for Mycoplasma Testing by Technique - Percentage Breakdown of Value Sales for Nucleic Acid Testing (NAT), ELISA, Staining and Other Techniques for the Years 2015, 2025 & 2030
    • TABLE 290: UAE Recent Past, Current & Future Analysis for Mycoplasma Testing by Application - Cell Line Testing, End-of-Production Cell Testing, Virus Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 291: UAE Historic Review for Mycoplasma Testing by Application - Cell Line Testing, End-of-Production Cell Testing, Virus Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 292: UAE 15-Year Perspective for Mycoplasma Testing by Application - Percentage Breakdown of Value Sales for Cell Line Testing, End-of-Production Cell Testing, Virus Testing and Other Applications for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 293: Rest of Middle East Recent Past, Current & Future Analysis for Mycoplasma Testing by Offering - Assays, Kits & Reagents, Services and Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 294: Rest of Middle East Historic Review for Mycoplasma Testing by Offering - Assays, Kits & Reagents, Services and Instruments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 295: Rest of Middle East 15-Year Perspective for Mycoplasma Testing by Offering - Percentage Breakdown of Value Sales for Assays, Kits & Reagents, Services and Instruments for the Years 2015, 2025 & 2030
    • TABLE 296: Rest of Middle East Recent Past, Current & Future Analysis for Mycoplasma Testing by Technique - Nucleic Acid Testing (NAT), ELISA, Staining and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 297: Rest of Middle East Historic Review for Mycoplasma Testing by Technique - Nucleic Acid Testing (NAT), ELISA, Staining and Other Techniques Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 298: Rest of Middle East 15-Year Perspective for Mycoplasma Testing by Technique - Percentage Breakdown of Value Sales for Nucleic Acid Testing (NAT), ELISA, Staining and Other Techniques for the Years 2015, 2025 & 2030
    • TABLE 299: Rest of Middle East Recent Past, Current & Future Analysis for Mycoplasma Testing by Application - Cell Line Testing, End-of-Production Cell Testing, Virus Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 300: Rest of Middle East Historic Review for Mycoplasma Testing by Application - Cell Line Testing, End-of-Production Cell Testing, Virus Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 301: Rest of Middle East 15-Year Perspective for Mycoplasma Testing by Application - Percentage Breakdown of Value Sales for Cell Line Testing, End-of-Production Cell Testing, Virus Testing and Other Applications for the Years 2015, 2025 & 2030
  • AFRICA
    • Mycoplasma Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 302: Africa Recent Past, Current & Future Analysis for Mycoplasma Testing by Offering - Assays, Kits & Reagents, Services and Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 303: Africa Historic Review for Mycoplasma Testing by Offering - Assays, Kits & Reagents, Services and Instruments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 304: Africa 15-Year Perspective for Mycoplasma Testing by Offering - Percentage Breakdown of Value Sales for Assays, Kits & Reagents, Services and Instruments for the Years 2015, 2025 & 2030
    • TABLE 305: Africa Recent Past, Current & Future Analysis for Mycoplasma Testing by Technique - Nucleic Acid Testing (NAT), ELISA, Staining and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 306: Africa Historic Review for Mycoplasma Testing by Technique - Nucleic Acid Testing (NAT), ELISA, Staining and Other Techniques Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 307: Africa 15-Year Perspective for Mycoplasma Testing by Technique - Percentage Breakdown of Value Sales for Nucleic Acid Testing (NAT), ELISA, Staining and Other Techniques for the Years 2015, 2025 & 2030
    • TABLE 308: Africa Recent Past, Current & Future Analysis for Mycoplasma Testing by Application - Cell Line Testing, End-of-Production Cell Testing, Virus Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 309: Africa Historic Review for Mycoplasma Testing by Application - Cell Line Testing, End-of-Production Cell Testing, Virus Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 310: Africa 15-Year Perspective for Mycoplasma Testing by Application - Percentage Breakdown of Value Sales for Cell Line Testing, End-of-Production Cell Testing, Virus Testing and Other Applications for the Years 2015, 2025 & 2030

IV. COMPETITION